Thermo Fisher Scientific Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9,852	4,009	8,077	8,524	4,477
Short-Term Investments	253	1,561	3	-	-
Cash & Short-Term Investments	10,105	5,570	8,080	8,524	4,477
Cash Growth	81.42%	-31.06%	-5.21%	90.40%	-56.64%
Accounts Receivable	8,900	9,626	9,664	9,427	8,945
Receivables	8,900	9,626	9,664	9,427	8,945
Inventory	5,425	4,978	5,088	5,634	5,051
Restricted Cash	-	10	6	12	13
Other Current Assets	4,277	1,953	1,751	1,632	1,627
Total Current Assets	28,707	22,137	24,589	25,229	20,113
Property, Plant & Equipment	10,565	10,795	11,004	10,873	9,864
Long-Term Investments	-	438	534	154	63
Goodwill	49,362	45,853	44,020	41,196	41,924
Other Intangible Assets	15,838	15,533	16,670	17,478	20,146
Long-Term Accounts Receivable	-	6	4	7	9
Other Long-Term Assets	5,871	2,559	1,905	2,217	3,004
Total Assets	110,343	97,321	98,726	97,154	95,123
Accounts Payable	-	3,079	2,872	3,381	2,867
Accrued Expenses	-	4,876	4,519	5,120	5,093
Short-Term Debt	-	-	-	310	2,522
Current Portion of Long-Term Debt	3,533	2,202	3,609	5,269	-
Current Portion of Leases	-	273	263	272	281
Current Unearned Revenue	-	2,852	2,689	2,601	2,655
Other Current Liabilities	11,656	50	60	57	18
Total Current Liabilities	15,189	13,332	14,012	17,010	13,436
Long-Term Debt	35,852	28,928	31,405	28,784	32,148
Long-Term Leases	-	1,429	1,434	1,523	1,388
Long-Term Unearned Revenue	-	1,138	1,499	1,179	1,238
Pension & Post-Retirement Benefits	-	355	383	323	504
Long-Term Deferred Tax Liabilities	-	1,268	1,922	2,849	3,837
Other Long-Term Liabilities	5,765	1,200	1,229	1,338	1,595
Total Liabilities	56,806	47,650	51,884	53,006	54,146
Common Stock	53,415	444	442	441	439
Additional Paid-In Capital	-	17,962	17,286	16,743	16,174
Retained Earnings	-	53,102	47,364	41,910	35,431
Treasury Stock	-	-19,226	-15,133	-12,017	-8,922
Comprehensive Income & Other	-	-2,698	-3,224	-3,099	-2,329
Total Common Equity	53,415	49,584	46,735	43,978	40,793
Minority Interest	122	87	107	170	184
Shareholders' Equity	53,537	49,671	46,842	44,148	40,977
Total Liabilities & Equity	110,343	97,321	98,726	97,154	95,123
Total Debt	39,385	32,832	36,711	36,158	36,339
Net Cash (Debt)	-29,280	-27,262	-28,631	-27,634	-31,862
Net Cash Per Share	-77.46	-71.18	-73.79	-70.14	-80.26
Filing Date Shares Outstanding	374	377.26	381.31	385.43	391.19
Total Common Shares Outstanding	374	380.77	386.65	390.51	394.43
Working Capital	13,518	8,805	10,577	8,219	6,677
Book Value Per Share	142.82	130.22	120.87	112.62	103.42
Tangible Book Value	-11,785	-11,802	-13,955	-14,696	-21,277
Tangible Book Value Per Share	-31.51	-30.99	-36.09	-37.63	-53.94
Land	-	439	458	454	431
Buildings	-	3,728	3,593	3,153	2,575
Machinery	-	9,858	9,235	7,967	7,020
Construction In Progress	-	2,034	2,238	2,695	2,567

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.